196 related articles for article (PubMed ID: 2535920)
21. The use of indomethacin, sulindac, and tamoxifen for the treatment of desmoid tumors associated with familial polyposis.
Klein WA; Miller HH; Anderson M; DeCosse JJ
Cancer; 1987 Dec; 60(12):2863-8. PubMed ID: 2824015
[TBL] [Abstract][Full Text] [Related]
22. Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis.
Nugent KP; Farmer KC; Spigelman AD; Williams CB; Phillips RK
Br J Surg; 1993 Dec; 80(12):1618-9. PubMed ID: 8298943
[TBL] [Abstract][Full Text] [Related]
23. Rectal proliferation and polyp occurrence in patients with familial adenomatous polyposis after sulindac treatment.
Spagnesi MT; Tonelli F; Dolara P; Caderni G; Valanzano R; Anastasi A; Bianchini F
Gastroenterology; 1994 Feb; 106(2):362-6. PubMed ID: 8299902
[TBL] [Abstract][Full Text] [Related]
24. Risk of cancer development in the rectal remnant of patients with familial adenomatous polyposis/Gardner's syndrome.
Matsumoto T; Iida M; Mibu R; Fujishima M
Hepatogastroenterology; 1995; 42(6):765-70. PubMed ID: 8847019
[TBL] [Abstract][Full Text] [Related]
25. Intestinal polyps in children and adolescents--a review of 103 cases.
Ko FY; Wu TC; Hwang B
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(3):197-202. PubMed ID: 7618471
[TBL] [Abstract][Full Text] [Related]
26. [Familial adenomatous polyposis: Gardner's syndrome].
Núñez Núñez R; Galán Gómez E; Moreno Hurtado C; Romero Albillo A; Santamaría Ossorio JI
Cir Pediatr; 2006 Apr; 19(2):111-4. PubMed ID: 16846135
[TBL] [Abstract][Full Text] [Related]
27. Rectal cancer after prolonged sulindac chemoprevention. A case report.
Lynch HT; Thorson AG; Smyrk T
Cancer; 1995 Feb; 75(4):936-8. PubMed ID: 7842414
[TBL] [Abstract][Full Text] [Related]
28. Clinical and genomic influence of sulindac on rectal mucosa in familial adenomatous polyposis.
Winde G; Schmid KW; Brandt B; Müller O; Osswald H
Dis Colon Rectum; 1997 Oct; 40(10):1156-68; discussion 1168-9. PubMed ID: 9336110
[TBL] [Abstract][Full Text] [Related]
29. Rectal cancer after sulindac therapy for a sporadic adenomatous colonic polyp.
Matsuhashi N; Nakajima A; Shinohara K; Oka T; Yazaki Y
Am J Gastroenterol; 1998 Nov; 93(11):2261-6. PubMed ID: 9820411
[TBL] [Abstract][Full Text] [Related]
30. The effect of sulindac on colon polyps: circumvention of a transformed phenotype--a hypothesis.
Waddell WR
J Surg Oncol; 1994 Jan; 55(1):52-5. PubMed ID: 8289454
[TBL] [Abstract][Full Text] [Related]
31. Diffuse abdominal uptake of technetium-99m-HDP after colectomy in Gardner's syndrome.
Alber TR; Scheidt KA; Fajman WA
J Nucl Med; 1995 Sep; 36(9):1611-4. PubMed ID: 7658220
[TBL] [Abstract][Full Text] [Related]
32. Sulindac in familial adenomatous polyposis: evaluation by nuclear morphometry.
Fernández-López F; Conde-Freire R; Cadarso-Suárez C; García-Iglesias J; Puente-Domínguez JL; Potel-Lesquereux J
Eur J Surg; 2001 May; 167(5):375-81. PubMed ID: 11419555
[TBL] [Abstract][Full Text] [Related]
33. [Gardner syndrome treated by total colectomy with preservation of the internal sphincter. Apropos of 3 cases].
Canarelli JP; Descombes P; Legraverend JM; Ringot PL; Collet LM; Bernard F; Quintard JM
Chir Pediatr; 1984; 25(3):179-85. PubMed ID: 6467491
[TBL] [Abstract][Full Text] [Related]
34. Eflornithine plus Sulindac for Prevention of Progression in Familial Adenomatous Polyposis.
Burke CA; Dekker E; Lynch P; Samadder NJ; Balaguer F; Hüneburg R; Burn J; Castells A; Gallinger S; Lim R; Stoffel EM; Gupta S; Henderson A; Kallenberg FG; Kanth P; Roos VH; Ginsberg GG; Sinicrope FA; Strassburg CP; Van Cutsem E; Church J; Lalloo F; Willingham FF; Wise PE; Grady WM; Ford M; Weiss JM; Gryfe R; Rustgi AK; Syngal S; Cohen A
N Engl J Med; 2020 Sep; 383(11):1028-1039. PubMed ID: 32905675
[TBL] [Abstract][Full Text] [Related]
35. Optimization of Erlotinib Plus Sulindac Dosing Regimens for Intestinal Cancer Prevention in an Apc-Mutant Model of Familial Adenomatous Polyposis (FAP).
Ulusan AM; Rajendran P; Dashwood WM; Yavuz OF; Kapoor S; Gustafson TA; Savage MI; Brown PH; Sei S; Mohammed A; Vilar E; Dashwood RH
Cancer Prev Res (Phila); 2021 Mar; 14(3):325-336. PubMed ID: 33277315
[TBL] [Abstract][Full Text] [Related]
36. Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study.
Cruz-Correa M; Hylind LM; Romans KE; Booker SV; Giardiello FM
Gastroenterology; 2002 Mar; 122(3):641-5. PubMed ID: 11874996
[TBL] [Abstract][Full Text] [Related]
37. Ileal adenomas in postcolectomy patients with familial adenomatosis coli/Gardner's syndrome. Incidence and endoscopic appearance.
Iida M; Itoh H; Matsui T; Mibu R; Iwashita A; Fujishima M
Dis Colon Rectum; 1989 Dec; 32(12):1034-8. PubMed ID: 2556253
[TBL] [Abstract][Full Text] [Related]
38. [A rare case of Gardner's syndrome complicated with rectal carcinoma].
Bliznashki I; Minev M; Mikhova A; Velev M
Khirurgiia (Sofiia); 2007; (3):60-3. PubMed ID: 18437113
[TBL] [Abstract][Full Text] [Related]
39. Results of surgical treatment for familial polyposis coli.
Heimann TM; Bolnick K; Aufses AH
Am J Surg; 1986 Sep; 152(3):276-8. PubMed ID: 3752376
[TBL] [Abstract][Full Text] [Related]
40. Prospective randomized study of sulindac versus calcium and calciferol for upper gastrointestinal polyps in familial adenomatous polyposis.
Seow-Choen F; Vijayan V; Keng V
Br J Surg; 1996 Dec; 83(12):1763-6. PubMed ID: 9038563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
